The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of vemurafenib and decitabine in metastatic melanoma.
 
Sneha Deepak Phadke
Employment - Vanda Pharmaceuticals (I)
Leadership - Vanda Pharmaceuticals (I)
Stock and Other Ownership Interests - Vanda Pharmaceuticals (I)
Consulting or Advisory Role - Vanda Pharmaceuticals (I)
Research Funding - Vanda Pharmaceuticals (I)
Patents, Royalties, Other Intellectual Property - Vanda Pharmaceuticals (I)
Travel, Accommodations, Expenses - Vanda Pharmaceuticals (I)
 
Eric Steven Engelman
No Relationships to Disclose
 
Roberto Antonio Leon-Ferre
No Relationships to Disclose
 
Laith I. Abushahin
No Relationships to Disclose
 
Sarah C Mott
No Relationships to Disclose
 
Yousef Zakharia
No Relationships to Disclose
 
Mohammed M. Milhem
No Relationships to Disclose